modelProcainamide_Grasela1984_reference
Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.
Information
| name: | procainamide |
| ATC code: | C01BA02 |
| model: | one compartment, IV dosing (PK_1C) |
| source: | Grasela TH et al. 1984 |
| population: | patients receiving procainamide |
| measured compound: | procainamide |
| review: | accepted with caveats |
| record page: | pharmacolibrary-docs |
Parameters as reported in the paper
| parameter | value | unit | meaning |
|---|---|---|---|
| CLR (L/h) | 14.4 | L/h | CLR |
| CLO (L/h) | 1.2 | L/h | CL |
| Vd (L) | 136.0 | L | V |
| F (Pronestyl®) | 0.85 | Pronestyl® | Fab |
| Time to peak (Pronestyl®) [hours] | 0.70 | hours | tmax |
| decrease_in_clr_and_cla_associated_with_chf | 0.11 | equation variable |
About procainamide
Procainamide is a class Ia antiarrhythmic used to treat heart rhythm problems such as atrial fibrillation and supraventricular tachycardia. It is an approved medicine, though it is not authorised in the European Union and is used mainly in other regions.
Summary written by glm-5.3-flash from Wikidata Q417597 and the WHO ATC classification; not checked by a person.
Identity, molar mass and metabolites: Procainamide.
References
Grasela TH et al. (1984). Population pharmacokinetics of procainamide from routine clinical data. Clinical pharmacokinetics 9(6):545–554. DOI:10.2165/00003088-198409060-00004 PUBMED:6509861
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| Real | Cl_ref | 3.333333333333333e-07 | Cl [m3/s] |
| Real | Vd_ref | 0.136 | Vd [m3] |
| Modelica.Units.SI.Mass | weight (from PK_1C) | 75 | patient weight (kg) |
| Modelica.Units.SI.SpecificVolume | VdPerKg (from PK_1C) | 0.0009 | Volume of distribution per kg (default 0.9 L/kg) |
| Modelica.Units.SI.MassFraction | F (from PK_1C) | 1 | bioavailability (0-1) |
| Pharmacolibrary.Types.Clearance | Cl (from PK_1C) | 2.7777777777777776e-7 | clearance |
| Modelica.Units.SI.Time | adminTime (from PK_1C) | 60 | first administration time (s) |
| Modelica.Units.SI.Time | adminDuration (from PK_1C) | 600 | administration duration (s) |
| Modelica.Units.SI.Time | adminPeriod (from PK_1C) | 8*60*60 | period of administration (default 8 hours)(s) |
| Pharmacolibrary.Types.Mass | adminMass (from PK_1C) | 1e-4 | administration mass (mg) |
| Integer | adminCount (from PK_1C) | 8 | number of dose administered (1) |
| Pharmacolibrary.Types.Volume | Vd (from PK_1C) | VdPerKg*weight | Volume of distribution (m3) |
| Info › Therapeutic range (metadata, not used in equations) | |||
| Pharmacolibrary.Types.MassConcentration | Cmin (from PK_1C) | 0.004 | minimal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Cmax (from PK_1C) | 0.008 | maximal therapeutic range |
| Pharmacolibrary.Types.MassConcentration | Ctox_peak (from PK_1C) | 0.012 | toxicity peak level |
| Pharmacolibrary.Types.MassConcentration | Ctox_trough (from PK_1C) | 0.006 | toxicity trough level |
| Info › Substance metadata | |||
| Modelica.Units.SI.MolarMass | MM (from PK_1C) | 0 | molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0) |
| Info › Substance metadata (not used in equations) | |||
| Pharmacolibrary.Types.Dose | LD50 (from PK_1C) | 0 | median lethal dose [mg/kg]; 0 = unknown |
Connectors
| Type | Name | Default | Description |
|---|---|---|---|
| Types.ConcentrationOutput | C_central (from PK_1C) | ||
| Interfaces.ConcentrationPort_b | centralCPort (from PK_1C) |
Components
| Type | Name | Default | Description |
|---|---|---|---|
| Pharmacokinetic.NoPerfusedTissueCompartment | central (from PK_1C) | ||
| Pharmacokinetic.ClearanceDrivenElimination | elim (from PK_1C) | ||
| Sources.PeriodicDose | periodicDose (from PK_1C) | ||
| Modelica.Units.SI.Time | t1_2 (from PK_1C) | central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models) |
Revisions
- 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Grasela_1984: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: accepted with caveats